Yield10 生物科學公司
US ˙ OTCPK

簡介

本頁面提供了有關 Nostrand Robert L Van 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Nostrand Robert L Van已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:SLS / SELLAS Life Sciences Group, Inc. Director 82,900
US:ITCI / Intra-Cellular Therapies, Inc. Director 0
US:YTEN / Yield10 Bioscience, Inc. Director 48,635
Director 0
US:ENUM / Enumeral Biomedical Holdings, Inc. Director 268,121
如何解讀這些圖表

以下圖表顯示了在Nostrand Robert L Van進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

YTENQ / Yield10 Bioscience, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 YTENQ / Yield10 Bioscience, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2012-11-30 MBLX VAN NOSTRAND ROBERT L 20,000 1.0700 20,000 1.0700 21,400 730

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

YTENQ / Yield10 Bioscience, Inc. Insider Trades
YTENQ / Yield10 Bioscience, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 YTENQ / Yield10 Bioscience, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

YTENQ / Yield10 Bioscience, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Nostrand Robert L Van 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-01-09 2026-01-07 4 SLS SELLAS Life Sciences Group, Inc.
Common Stock
A - Award 50,000 82,900 151.98
2025-06-13 2025-06-12 4 SLS SELLAS Life Sciences Group, Inc.
Common Stock
P - Purchase 10,000 20,400 96.15 1.48 14,800 30,192
2025-04-02 2025-04-02 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
D - Sale to Issuer -11,340 0 -100.00 132.00 -1,496,880
2025-01-14 2025-01-10 4 SLS SELLAS Life Sciences Group, Inc.
Common Stock
A - Award 12,500 22,900 120.19
2024-07-02 2024-06-28 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 83 11,340 0.74 68.49 5,685 776,677
2024-06-25 2024-06-23 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 1,567 11,257 16.17
2024-06-21 2024-06-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -11,109 9,690 -53.41 76.07 -845,062 737,118
2024-06-21 2024-06-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -8,891 20,799 -29.95 75.71 -673,138 1,574,692
2024-06-21 2024-06-18 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 20,000 29,690 206.40 16.86 337,200 500,573
2024-04-02 2024-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 79 9,690 0.82 69.20 5,467 670,548
2024-04-01 2024-03-28 4 YTEN YIELD10 BIOSCIENCE, INC.
Common Stock
A - Award 11,924 48,635 32.48
2024-02-28 2024-02-27 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -10,349 9,611 -51.85 73.14 -756,926 702,949
2024-02-28 2024-02-27 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -9,651 19,960 -32.59 72.71 -701,724 1,451,292
2024-02-28 2024-02-27 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 20,000 29,611 208.09 18.56 371,200 549,580
2024-01-25 2024-01-22 4 SLS SELLAS Life Sciences Group, Inc.
Common Stock
A - Award 6,000 10,400 136.36
2024-01-03 2023-12-29 4 YTEN YIELD10 BIOSCIENCE, INC.
Common Stock
A - Award 18,879 36,711 105.87
2024-01-03 2023-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 76 9,611 0.80 71.62 5,443 688,340
2023-10-02 2023-09-29 4 YTEN YIELD10 BIOSCIENCE, INC.
Common Stock
A - Award 13,868 17,832 349.85
2023-10-02 2023-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 105 9,535 1.11 52.09 5,469 496,678
2023-07-05 2023-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 85 9,430 0.91 63.32 5,382 597,108
2023-07-05 2023-06-30 4 YTEN YIELD10 BIOSCIENCE, INC.
Common Stock
A - Award 2,040 3,964 106.03
2023-04-19 2023-04-17 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale X -10,000 9,345 -51.69 63.00 -630,000 588,735
2023-04-19 2023-04-17 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 10,000 19,345 107.01 13.05 130,500 252,452
2023-04-04 2023-03-31 4 YTEN YIELD10 BIOSCIENCE, INC.
Common Stock
A - Award 1,642 1,924 582.27
2023-04-04 2023-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 95 9,345 1.03 54.15 5,144 506,032
2023-02-03 2023-02-02 4 SLS SELLAS Life Sciences Group, Inc.
Common Stock
A - Award 2,500 4,400 131.58
2023-01-03 2022-12-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 97 9,250 1.06 52.92 5,133 489,510
2022-10-05 2022-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 110 9,153 1.22 46.53 5,118 425,889
2022-08-12 2022-08-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -1,500 9,043 -14.23 56.80 -85,200 513,642
2022-08-12 2022-08-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
S - Sale -28,500 10,543 -73.00 57.15 -1,628,775 602,532
2022-08-12 2022-08-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 10,000 39,043 34.43 13.05 130,500 509,511
2022-08-12 2022-08-11 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
M - Exercise 20,000 29,043 221.17 12.45 249,000 361,585
2022-07-05 2022-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 108 9,043 1.21 57.08 6,165 516,174
2022-05-26 2022-05-25 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 5,000 5,000
2022-04-04 2022-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 126 8,935 1.43 61.19 7,710 546,733
2022-04-04 2022-03-31 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 908 908 4.99 4,531 4,531
2022-02-01 2022-01-31 4 SLS SELLAS Life Sciences Group, Inc.
Stock Option (Right to Buy)
A - Award 7,125 7,125
2022-02-01 2022-01-31 4 SLS SELLAS Life Sciences Group, Inc.
Common Stock
A - Award 1,900 1,900
2022-01-04 2021-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 148 8,809 1.71 52.34 7,746 461,063
2022-01-03 2021-12-31 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 976 976 4.64 4,529 4,529
2021-10-04 2021-09-30 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 801 801 5.66 4,534 4,534
2021-10-04 2021-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 215 8,661 2.55 37.28 8,015 322,882
2021-07-02 2021-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 173 8,446 2.09 40.82 7,062 344,766
2021-07-01 2021-06-30 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 562 562 8.06 4,530 4,530
2021-06-22 2021-06-21 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2021-05-26 2021-05-24 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 5,000 5,000
2021-04-02 2021-03-31 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 383 383 11.84 4,535 4,535
2021-04-02 2021-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 208 8,273 2.58 33.93 7,057 280,703
2021-03-08 2021-03-04 4 SLS SELLAS Life Sciences Group, Inc.
Stock Option (Right to Buy)
A - Award 7,500 7,500
2021-01-05 2020-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 222 8,065 2.83 31.80 7,060 256,467
2021-01-04 2020-12-31 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 818 818 5.54 4,532 4,532
2020-10-02 2020-09-30 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 624 624 7.26 4,530 4,530
2020-10-02 2020-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 276 7,843 3.65 25.66 7,082 201,251
2020-07-02 2020-06-30 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 777 777 5.84 4,538 4,538
2020-07-02 2020-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 275 7,567 3.77 25.67 7,059 194,245
2020-05-29 2020-05-28 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 5,000 5,000
2020-05-28 2020-05-27 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2020-04-02 2020-03-31 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 1,294 1,294 3.50 4,529 4,529
2020-04-02 2020-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 460 7,292 6.73 15.37 7,070 112,078
2020-03-16 2020-03-12 4 SLS SELLAS Life Sciences Group, Inc.
Stock Option (Right to Buy)
A - Award 6,500 6,500
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
D - Sale to Issuer -42,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
D - Sale to Issuer -30,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
D - Sale to Issuer -30,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
D - Sale to Issuer -25,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
D - Sale to Issuer -50,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
D - Sale to Issuer -30,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Options (Right to buy)
D - Sale to Issuer -20,000 0 -100.00
2020-01-29 2020-01-28 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -40,000 0 -100.00 6.30 -252,000
2020-01-03 2019-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 170 6,832 2.55 34.31 5,833 234,406
2019-12-19 2019-12-18 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -20,000 0 -100.00
2019-12-19 2019-12-18 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
M - Exercise 20,000 40,000 100.00 3.28 65,600 131,200
2019-10-02 2019-09-30 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 9,845 9,845 0.46 4,529 4,529
2019-10-02 2019-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 780 6,662 13.26 7.47 5,827 49,765
2019-07-02 2019-06-28 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 5,096 5,096 0.89 4,535 4,535
2019-07-02 2019-06-28 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 449 5,882 8.26 12.98 5,828 76,348
2019-06-26 2019-06-25 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2019-05-23 2019-05-22 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 10,000 10,000
2019-04-02 2019-03-29 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 4,321 4,321 1.05 4,537 4,537
2019-04-02 2019-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 478 5,433 9.65 12.18 5,822 66,174
2019-03-18 2019-03-14 4 SLS SELLAS Life Sciences Group, Inc.
Stock Option (Right to Buy)
A - Award 25,000 25,000
2019-01-25 2019-01-23 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to buy)
A - Award 42,000 42,000
2019-01-03 2018-12-31 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 5,924 5,924 0.76 4,502 4,502
2019-01-03 2018-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 512 4,955 11.52 11.39 5,832 56,437
2018-12-18 2018-12-14 4 ACHN ACHILLION PHARMACEUTICALS INC
Employee Stock Option
M - Exercise -20,000 0 -100.00
2018-12-18 2018-12-14 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock
M - Exercise 20,000 20,000 1.05 21,000 21,000
2018-10-02 2018-09-28 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 3,396 3,396 1.33 4,517 4,517
2018-10-02 2018-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 268 4,443 6.42 21.70 5,816 96,413
2018-07-03 2018-06-29 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 3,464 3,464 1.31 4,538 4,538
2018-07-03 2018-06-29 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 282 4,175 7.24 17.67 4,983 73,772
2018-06-20 2018-06-18 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2018-06-13 2018-06-12 4 SLS SELLAS Life Sciences Group, Inc.
Stock Option (Right to Buy)
A - Award 5,500 5,500
2018-05-25 2018-05-23 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 10,000 10,000
2018-04-03 2018-03-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 237 3,893 6.48 21.05 4,989 81,948
2018-04-02 2018-03-29 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 2,860 2,860 1.58 4,519 4,519
2018-03-15 2018-03-13 4 SLS SELLAS Life Sciences Group, Inc.
Stock Option (Right to Buy)
A - Award 11,000 11,000
2018-02-13 2018-02-09 4 ACHN ACHILLION PHARMACEUTICALS INC
Employee Stock Option
A - Award 30,000 30,000
2018-01-03 2017-12-29 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
P - Purchase 345 3,656 10.42 14.48 4,996 52,939
2018-01-03 2017-12-29 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 13,003 13,003 1.39 18,074 18,074
2018-01-03 2017-12-29 4/A ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 345 3,656 10.42 14.48 4,996 52,939
2017-12-29 3 SLS SELLAS Life Sciences Group, Inc.
Common Stock
0
2017-11-30 2017-11-28 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 10,165 10,165
2017-10-03 2017-09-29 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 316 3,311 10.55
2017-07-05 2017-06-30 4 YTEN YIELD10 BIOSCIENCE, INC.
Common Stock
A - Award 3,519 11,293 45.27
2017-07-05 2017-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 402 2,995 15.50
2017-06-29 2017-06-27 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2017-05-26 2017-05-24 4 YTEN YIELD10 BIOSCIENCE, INC.
Stock Option (right to buy)
A - Award 25,000 25,000
2017-05-26 2017-05-24 4 YTEN YIELD10 BIOSCIENCE, INC.
Common Stock
A - Award 43,155 46,488 1,294.78
2017-04-04 2017-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 307 2,593 13.43
2017-01-19 2017-01-19 4 ACHN ACHILLION PHARMACEUTICALS INC
Employee Stock Option
A - Award 30,000 30,000
2017-01-05 2017-01-03 4 ENUM Enumeral Biomedical Holdings, Inc.
Common Stock
A - Award 66,666 268,121 33.09
2017-01-03 2016-12-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 331 2,286 16.93
2016-12-13 2016-12-09 4 ENUM Enumeral Biomedical Holdings, Inc.
Common Stock Purchase Warrant
M - Exercise -156,000 0 -100.00 0.12 -19,500
2016-12-13 2016-12-09 4 ENUM Enumeral Biomedical Holdings, Inc.
Common Stock Purchase Warrant
J - Other 156,000 156,000 0.12 19,500 19,500
2016-12-13 2016-12-09 4 ENUM Enumeral Biomedical Holdings, Inc.
Common Stock Purchase Warrant
P - Purchase 39,000 39,000 0.08 3,120 3,120
2016-12-13 2016-12-09 4 ENUM Enumeral Biomedical Holdings, Inc.
Common Stock
M - Exercise 156,000 201,455 343.20 0.12 19,500 25,182
2016-10-04 2016-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 328 1,955 20.16
2016-07-05 2016-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 128 1,627 8.54
2016-06-15 2016-06-14 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2016-04-04 2016-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 134 1,499 9.82
2016-01-27 2016-01-25 4 ACHN ACHILLION PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 30,000 30,000
2016-01-06 2016-01-04 4 ENUM Enumeral Biomedical Holdings, Inc.
Common Stock
A - Award 45,455 45,455
2016-01-05 2015-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 69 1,365 5.32 53.79 3,712 73,423
2015-10-02 2015-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 93 1,296 7.73
2015-09-24 2015-09-22 4 ENUM Enumeral Biomedical Holdings, Inc.
Common Stock Option (Right to Buy)
A - Award 76,000 76,000
2015-09-14 2015-09-10 4 MBLX METABOLIX, INC.
Common Stock
A - Award 31,250 31,250
2015-07-02 2015-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 117 1,203 10.77
2015-06-22 2015-06-16 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2015-04-03 3 ENUM Enumeral Biomedical Holdings, Inc.
Common Stock
0
2015-04-02 2015-03-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 157 1,086 16.90
2015-01-05 2014-12-31 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 212 929 29.57
2014-12-04 2014-12-02 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock (Right to Buy)
A - Award 25,000 25,000
2014-10-02 2014-09-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 273 717 61.49
2014-07-02 2014-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2014-07-02 2014-06-30 4 ITCI Intra-Cellular Therapies, Inc.
Common Stock
A - Award 444 444
2014-05-29 2014-05-28 4 MBLX METABOLIX, INC.
Stock Option
A - Award 25,000 25,000
2014-03-24 2014-03-21 4 ITCI Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2014-03-13 2014-01-02 4/A MBLX METABOLIX, INC.
Stock Option (right to buy)
A - Award 50,000 50,000
2014-01-06 2014-01-02 4 MBLX METABOLIX, INC.
Stock Option (right to buy)
A - Award 50,000 50,000
2013-12-19 2013-12-17 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock (Right to Buy)
A - Award 25,000 25,000
2013-06-10 2013-06-06 4 MBLX METABOLIX, INC.
Stock Option
A - Award 10,000 10,000
2012-12-20 2012-12-18 4 ACHN ACHILLION PHARMACEUTICALS INC
Common Stock (Right to Buy)
A - Award 20,000 20,000
2012-12-04 2012-11-30 4 MBLX METABOLIX, INC.
Common Stock
P - Purchase 20,000 20,000 1.07 21,400 21,400
2012-06-11 2012-06-07 4 MBLX METABOLIX, INC.
Stock Option (right to buy)
A - Award 10,000 10,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)